Induction by anti-thymocyte globulins in kidney transplantation: a review of the literature and current usage
Context: Preventing acute rejection (AR) after kidney transplantation is of utmost importance because an AR can have a negative impact on long-term allograft survival. Evidence Acquisition: Directory of Open Access Journals (DOAJ), Google Scholar, PubMed, EBSCO, and Web of Science have been searched...
Main Authors: | Paolo Malvezzi, Thomas Jouve, Lionel Rostaing |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Diabetic Nephropathy Prevention
2015-10-01
|
Series: | Journal of Nephropathology |
Subjects: | |
Online Access: | https://nephropathol.com/PDF/JNP-4-110.pdf |
Similar Items
-
Modest dose anti-thymocyte globulin administered intraoperatively is safe and effective in kidney transplantations: a retrospective study
by: Hui-Ying Liu, et al.
Published: (2019-08-01) -
Comparison of Alemtuzumab and Anti-thymocyte Globulin Treatment for Acute Kidney Allograft Rejection
by: Marieke van der Zwan, et al.
Published: (2020-07-01) -
Impact of Induction Immunosuppressants on T Lymphocyte Subsets after Kidney Transplantation: A Prospective Observational Study with Focus on Anti-Thymocyte Globulin and Basiliximab Induction Therapies
by: Hyung Duk Kim, et al.
Published: (2023-09-01) -
The Anti-thymocyte Globulin use makes kidney transplantation journey smooth
by: Akbar Mahmood Sultan, et al.
Published: (2018-06-01) -
Outcome Comparison between Low-Dose Rabbit Anti-Thymocyte Globulin and Basiliximab in Low-Risk Living Donor Kidney Transplantation
by: Sang Jin Kim, et al.
Published: (2020-05-01)